Literature DB >> 23369201

Quality of life after adult living donor liver transplantation: A longitudinal prospective follow-up study.

Junichi Togashi1, Yasuhiko Sugawara, Nobuhisa Akamatsu, Sumihito Tamura, Noriyo Yamashiki, Junichi Kaneko, Yoshihiro Sakamoto, Taku Aoki, Kiyoshi Hasegawa, Norihiro Kokudo.   

Abstract

AIM: Patient survival after living donor liver transplantation (LDLT) has improved, but improvement of the health-related quality of life (HRQOL) of LDLT recipients is also an important issue. The aim of this study was to assess the HRQOL of LDLT recipients from the preoperative period to 18 months following transplantation by prospectively evaluating Short Form-36 Version 2 (SF-36v2) scores.
METHODS: Complete longitudinal SF-36v2 scores were collected from 35 consecutive LDLT recipients prior to surgery and at 3, 6, 12 and 18 months after transplantation.
RESULTS: HRQOL scores were severely impaired in all dimensions preoperatively. Although the scores improved significantly up to 18 months after transplantation, they remained lower than those of healthy controls in the majority of domains. Impaired scores preoperatively were significantly associated with severity of liver disease represented by a higher Model for End-Stage Liver Disease (MELD) score and Child-Turcotte-Pugh class C, and scores in such patients improved significantly after LDLT in every dimension at 12 months, indicating that the greater the impairment at the pretransplant stage, the greater the improvement in both physical and mental conditions. Preoperative lower HRQOL scores and higher MELD scores were independently associated with significant physical and mental score gains during the first year after LDLT.
CONCLUSION: The findings of the present study may facilitate the development of measures aimed at improving recipient's post-transplant life and establishing realistic expectations for LDLT recipients.
© 2013 The Japan Society of Hepatology.

Entities:  

Keywords:  Short Form-36; health-related quality of life; liver transplantation; living donor liver transplantation; quality of life; recipient

Year:  2013        PMID: 23369201     DOI: 10.1111/hepr.12060

Source DB:  PubMed          Journal:  Hepatol Res        ISSN: 1386-6346            Impact factor:   4.288


  6 in total

1.  Health-related quality of life and affective status in liver transplant recipients and patients on the waiting list with low MELD scores.

Authors:  Christian Benzing; Nicco Krezdorn; Julia Förster; Andreas Hinz; Felix Krenzien; Georgi Atanasov; Moritz Schmelzle; Hans-Michael Hau; Michael Bartels
Journal:  HPB (Oxford)       Date:  2016-04-20       Impact factor: 3.647

2.  Analysis of Quality of Life, Depression, and Sexual Function in Patients on the Liver Transplant List.

Authors:  Cihan Fidan; Aydıncan Akdur; Mahir Kırnap; Haldun Selçuk; Sedat Yıldırım; Gökhan Moray; Mehmet Haberal
Journal:  Turk J Gastroenterol       Date:  2021-09       Impact factor: 1.555

3.  Prediction of postoperative mortality in liver transplantation in the era of MELD-based liver allocation: a multivariate analysis.

Authors:  Helge Bruns; Vladimir J Lozanovski; Daniel Schultze; Norbert Hillebrand; Ulf Hinz; Markus W Büchler; Peter Schemmer
Journal:  PLoS One       Date:  2014-06-06       Impact factor: 3.240

4.  Assessment of relevant factors with respect to psychosocial properties in potential living donor candidates before liver transplantation.

Authors:  Ming-Kung Wu; Li-Wen Hsu; Kuang-Tzu Huang; Chih-Che Lin; Chih-Chi Wang; Ting-Lung Lin; Wei-Feng Li; Shigeru Goto; Chao-Long Chen; Chien-Chih Chen
Journal:  Neuropsychiatr Dis Treat       Date:  2018-08-08       Impact factor: 2.570

5.  MELD Score Reflects the Mood, Sleep, and Daily Living Ability in Liver Transplantation Candidates: A Descriptive Study.

Authors:  Kaiji Ni; Chenglin Li; Yongbing Qian; Xia Sun; Yan Zhan; Ting Zeng; Siqi Zhu; Qiang Xia; Wei Feng; Yanli Luo
Journal:  Ann Transplant       Date:  2020-12-01       Impact factor: 1.530

6.  Liver Transplantation for Quality as well as Quantity of Life.

Authors:  Kamran B Lankarani
Journal:  Hepat Mon       Date:  2013-10-01       Impact factor: 0.660

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.